64764-800 : Livtencity 200 mg Oral Tablet, Coated


NDC64764-800
Labeler: Takeda Pharmaceuticals America, Inc.
Product Type: Human Prescription Drug
Drug Name:  Livtencity
Dosage Form: Oral Tablet, Coated
Application #: NDA215596
Rev. Date: 


NDC Package Codes:

  • 64764-800-28: 1 BOTTLE IN 1 CARTON (64764‑800‑28) > 28 TABLET, COATED IN 1 BOTTLE
  • 64764-800-56: 1 BOTTLE IN 1 CARTON (64764‑800‑56) > 56 TABLET, COATED IN 1 BOTTLE

Active Ingredients:

  • Maribavir

Dosage Strength:

  • 200 mg

Pharmaceutical Classes:

  • Breast Cancer Resistance Protein Inhibitors [MoA]
  • Cytochrome P450 3A4 Inhibitors [MoA]
  • Cytomegalovirus pUL97 Kinase Inhibitor [EPC]
  • Cytomegalovirus pUL97 Kinase Inhibitors [MoA]
  • P-Glycoprotein Inhibitors [MoA]

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 64764-800 QR Code

< Prev: 64764-750Next: 64764-805 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.